Smarter Solutions.
Better Outcomes. Better Health.

Soluzioni diagnostiche semplici, innovative e sostenibili

Realizziamo una diagnostica innovativa, centrata sul paziente e con accuratezza da laboratorio, che sta trasformando l’assistenza sanitaria territoriale. I nostri prodotti sono utilizzati da governi e importanti istituzioni sanitarie in laboratori, centri di primo soccorso, ambulatori medici, farmacie, scuole, case di cura e luoghi di lavoro per lo screening, la diagnosi e il monitoraggio dello stato di benessere e di malattia.

I nostri prodotti sono soluzioni di nuova generazione che si servono di dati e di una tecnologia basata su cloud per sviluppare piani di supporto all’autocura finalizzati a migliorare la salute dei singoli individui e l’efficienza dei sistemi sanitari. Impegniamo tutte le nostre capacità e la nostra esperienza per dare vita a soluzioni diagnostiche intelligenti, accessibili e sostenibili.

Collaborazione e competenza

ECCO I NOSTRI LEADER

Veronique Ameye EMBA

Chief Executive Officer e General Counsel

Dorian LeBlanc

Chief Financial Officer

David Walton

Chief Commercial Officer

Entra a far parte della nostra squadra e lascia il tuo segno nel mondo

Pubblicazioni correlate

White paperPDF

St Malo Evaluation of LumiraDx Analyzer for decentralized CRP testing
The availability of CRP blood testing is important in emergency medicine to ensure the relevance of the antibiotic therapy prescription. Its use in decentralized laboratory testing requires comparing the methods to the laboratory reference technique. The LumiraDx TM CRP test is a microfluidic immunoassay to quantify CRP levels in whole blood and plasma samples in 4 minutes.
Visualizza link

White paperPDF

St Malo: How the health crisis changed our approach to decentralized laboratory testing
The global SARS-COV2 pandemic has profoundly changed the organization of healthcare services and regional hospital groups. Delocalized laboratory testing has quickly adapted to three challenges. It was first necessary to respond to the growing demand for ABG testing for “ephemeral resuscitation” and the management of respiratory distress. Then came the time for mass viral detection. Unlike the Rapid Diagnostic Test (RDT), decentralized laboratory testing could offer reliable, rapid tests in under 5 minutes, that were traceable and that met the quality criteria (Rapid and Connectable Point-of-Care COVID-19 Coulon et al. Diagnostics 2023,13,3508). Finally, the resurgence of COVID epidemic waves with influenza or RSV epidemics required the development of combined antigen tests.
Visualizza link

White paperPDF

St. Malo evaluation of POC biology platform: A solution for emergency departments and nursing homes?
To refer primary care patients to specialist centers or local healthcare facilities, Point of Care tests must meet NF EN ISO 15189 quality criteria, be reliable and traceable to the electronic medical record. The aim of this work is to validate the CRP, NT-proBNP and HbA1C tests on the LumiraDx platform.
Visualizza link
Per saperne di più